This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Excelsior Pharmatech Labs, National Taiwan University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1,392 
Years Active: 2023
Title: Innovations of Mei-Hwan Wu in Cardiomyopathy Treatment
Introduction
Mei-Hwan Wu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of non-compaction cardiomyopathy. His innovative approach has garnered attention in the medical community.
Latest Patents
Mei-Hwan Wu holds 1 patent for a method aimed at treating non-compaction cardiomyopathy. This patent describes a method for treating a subject suffering from this condition by administering a pharmaceutical composition that includes a therapeutically effective amount of an EZH2 downregulator, such as a statin.
Career Highlights
Throughout his career, Mei-Hwan Wu has worked with esteemed institutions, including National Taiwan University and Excelsior Pharmatech Labs. His work in these organizations has allowed him to develop and refine his innovative methods for treating complex medical conditions.
Collaborations
Mei-Hwan Wu has collaborated with notable colleagues, including Hong-Nerng Ho and Wen-Pin Chen. These partnerships have contributed to the advancement of his research and the development of effective treatment methods.
Conclusion
Mei-Hwan Wu's contributions to the treatment of non-compaction cardiomyopathy highlight his innovative spirit and dedication to improving patient outcomes. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile